Applied Therapeutics Provides Regulatory Update on Galactosemia Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- Market watchers weigh chances of a surprise Fed rate hike tomorrow
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
Applied Therapeutics Inc. (APLT) Declines 50% After Shares Resume Trading
January 3, 2022 7:32 AM ESTApplied Therapeutics Inc. (NASDAQ: APLT) Declines 50% After Shares Resume Trading
... MoreApplied Therapeutics Inc. (APLT) to Resume Trading at 7:30 a.m.
January 3, 2022 7:05 AM ESTApplied Therapeutics Inc. (NASDAQ: APLT) to Resume Trading at 7:30 a.m.
... More